Insider · CIK 0001133921

SCHUHSLER HELMUT

Reports to the SEC for 5 companies · MUNICH, 2M

sec.gov

Transactions

Companies

Filings

CIK

0001133921

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-06-11	CONCERT PHARMACEUTICALS, INC.Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2014-02-24	ENTAENANTA PHARMACEUTICALS INCS Sale	10% Owner	SSale	−8,130 sh	$39.51	−$321K	380,487
2014-02-24	ENTAENANTA PHARMACEUTICALS INCS Sale	10% Owner	SSale	−10.9K sh	$39.51	−$429K	508,485
2014-02-24	ENTAENANTA PHARMACEUTICALS INCS Sale	10% Owner	SSale	−33.6K sh	$39.51	−$1.33M	1,572,670
2014-02-21	ENTAENANTA PHARMACEUTICALS INCS Sale	10% Owner	SSale	−1,218 sh	$40.00	−$48.7K	388,617
2014-02-21	ENTAENANTA PHARMACEUTICALS INCS Sale	10% Owner	SSale	−1,628 sh	$40.00	−$65.1K	519,350
2014-02-21	ENTAENANTA PHARMACEUTICALS INCS Sale	10% Owner	SSale	−5,034 sh	$40.00	−$201K	1,606,272
2014-02-18	ENTAENANTA PHARMACEUTICALS INCS Sale	10% Owner	SSale	−1,546 sh	$40.32	−$62.3K	389,935
2014-02-18	ENTAENANTA PHARMACEUTICALS INCS Sale	10% Owner	SSale	−5,066 sh	$40.32	−$204K	520,978
2014-02-18	ENTAENANTA PHARMACEUTICALS INCS Sale	10% Owner	SSale	−6,388 sh	$40.32	−$258K	1,611,306
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+236K sh	—	—	236,065
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+351K sh	—	—	587,079
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+155K sh	—	—	742,395
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+172K sh	—	—	914,425
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+1.01M sh	—	—	1,920,923
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+478K sh	—	—	2,399,170
2013-03-26	ENTAENANTA PHARMACEUTICALS INCP Purchase	10% Owner	PPurchase	+133K sh	$14.00	+$1.86M	2,532,119
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.02M sh	—	—	0
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.13M sh	—	—	500,000
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−500K sh	—	—	0
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series E Convertible Preferred StockC Conversion	10% Owner	CConversion	−564K sh	—	—	3,296,888
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series E Convertible Preferred StockC Conversion	10% Owner	CConversion	−3.3M sh	—	—	0
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series G-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−2.06M sh	—	—	0
2013-03-20	ENTAENANTA PHARMACEUTICALS INC · Common Stock Option (right to buy)A Award	10% Owner	AAward	+5,800 sh	—	—	5,800

Recent filings

Accepted (ET)
Jun 154
CONCERT PHARMACEUTICALS, INC.0001209191-15-053246
SEC(opens sec.gov)
Feb 254
ENANTA PHARMACEUTICALS INC0001012975-14-000112
SEC(opens sec.gov)
Feb 204
ENANTA PHARMACEUTICALS INC0001012975-14-000102
SEC(opens sec.gov)
Mar 284
SCHUHSLER HELMUT0001012975-13-000127
SEC(opens sec.gov)

Companies

Address

C/O TVM CAPITAL MAXIMILIANSTRASSE 35C

MUNICH, 2M, 80539